Renaissance Technologies LLC 13D and 13G filings for Crescent Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 12:06 pm Sale | 2022-12-30 | 13G | Crescent Biopharma, Inc. CBIO | Renaissance Technologies LLC | 791 3.140% | -3,701 (-82.39%) | Filing |
| 2022-02-11 4:16 pm Purchase | 2021-12-27 | 13G | Crescent Biopharma, Inc. CBIO | Renaissance Technologies LLC | 4,492 5.640% | 3,988 (+790.41%) | Filing |